MyFinsight
Home
About
Contact
Back
Income Statement
Medtronic plc (MDT)
source: myfinsight.com
Download
Download image
Cardiovascular
$3,285M
(9.25%↑ Y/Y)
Diabetes Group
$721M
(11.44%↑ Y/Y)
Medical Surgical
$2,083M
(4.36%↑ Y/Y)
Neuroscience Group
$2,416M
(4.27%↑ Y/Y)
Other
adjustments-Consolidation Eliminations
$39M
All Other
Segments-Operating Segments
$33M
(-13.16%↓ Y/Y)
Operating Segments
$8,506M
Net sales
$8,578M
(8.38%↑ Y/Y)
Operating profit
$1,445M
(13.07%↑ Y/Y)
Other non-operating
income, net
$33M
(-78.98%↓ Y/Y)
Restructuring charges, net
$45M
(-4.26%↓ Y/Y)
Amortization of intangible
assets
$459M
(10.87%↑ Y/Y)
Cost of products
sold, excluding...
$3,001M
(8.69%↑ Y/Y)
Certain litigation
charges, net
$27M
(-66.67%↓ Y/Y)
Other operating
expense, net
-$70M
(-6900.00%↓ Y/Y)
Research and development
expense
$726M
(7.40%↑ Y/Y)
Selling, general, and
administrative expense
$2,806M
(5.69%↑ Y/Y)
Income before income
taxes
$1,302M
(2.68%↑ Y/Y)
Interest expense, net
$176M
(5.39%↑ Y/Y)
Net income
$1,047M
(-0.19%↓ Y/Y)
Income tax provision
$255M
(15.91%↑ Y/Y)
Net income
attributable to medtronic
$1,040M
(-0.19%↓ Y/Y)
Net income
attributable to...
$7M
(16.67%↑ Y/Y)
Back